CD274 and esophageal cancer: In summary, although this study provides preliminary evidence for optimizing the surgery interval to improve survival outcomes in esophageal cancer patients, our analysis did not incorporate key molecular variables, such as tumor mutational burden, PD-L1 expression, or genetic alterations, which may influence both treatment sensitivity and the optimal timing of surgery.